InflaRx
-$0.09 (-6.25%) As of 1:43 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.
About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is vilobelimab.
CEO
Niels Christoph Riedemann
Employees
59
Headquarters
Jena, Thueringen
Founded
2007
IFRX Key Statistics
Market cap
59.68M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.11M
High today
$1.46
Low today
$1.35
Open price
$1.46
Volume
9.32K
52 Week high
$5.69
52 Week low
$0.7762
Analyst ratings
50%
of 6 ratings
Buy
50%
Hold
16.7%
Sell
33.3%
IFRX Earnings
-$0.40
-$0.27
-$0.13
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market